about
Evolutionary divergence and functions of the human interleukin (IL) gene familyTreatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)The interleukin-17 cytokine family: critical players in host defence and inflammatory diseasesPathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17AThe emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findingsIL-17RC: a partner in IL-17 signaling and beyondStructural basis of receptor sharing by interleukin 17 cytokinesSecukinumab for rheumatology: development and its potential place in therapyThe roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunityCytokine-Induced Modulation of Colorectal CancerThe IL-17A G-197A and IL-17F 7488T/C polymorphisms are associated with increased risk of cancer in Asians: a meta-analysisInterleukin 17-Mediated Host Defense against Candida albicansNF-κB, the first quarter-century: remarkable progress and outstanding questionsInflammation, immunity, and hypertensive end-organ damageJanus kinase inhibitors in autoimmune diseasesCell type- and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expressionMucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapyNF-κB in inflammation and renal diseasesAntimicrobial proteins in intestine and inflammatory bowel diseasesIL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease ProgressionInterleukin-17 and acute coronary syndromeTargeting of interleukin-17 in the treatment of psoriasisExtensive expression differences along porcine small intestine evidenced by transcriptome sequencingStructure of the unique SEFIR domain from human interleukin 17 receptor A reveals a composite ligand-binding site containing a conserved α-helix for Act1 binding and IL-17 signalingCrystal structures of interleukin 17A and its complex with IL-17 receptor ASecukinumab: A New Treatment Option for Psoriatic ArthritisThe Role of Interleukin-17 in Lung CancerRole of Interleukin 17 in Lung Carcinogenesis and Lung Cancer ProgressionInterleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseasesEffect of IL-17 receptor A blockade with brodalumab in inflammatory diseasesEvolution of the IL17 receptor family in chordates: a new subfamily IL17RELCytokines in psoriasisEndogenous modulators of inflammatory cell recruitmentIL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tailThe Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the KidneyNeuroprotection effect of interleukin (IL)-17 secreted by reactive astrocytes is emerged from a high-level IL-17-containing environment during acute neuroinflammationInvolvement of interleukin-17A in pancreatic damage in rat experimental acute necrotizing pancreatitisMacrophages participate in IL-17-mediated inflammationReassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosisIL-17A/F-signaling does not contribute to the initial phase of mucosal inflammation triggered by S. Typhimurium
P2860
Q21245454-A85927C1-D613-4385-BABD-CF84ACCF8A3FQ24319867-8AC1FF9B-3320-4295-BB65-A8B3F5F6AE1EQ24594675-F90D6630-A441-429E-A965-F81990DB78B7Q24597173-FEDB44E1-7540-423F-9E01-1473D816D241Q24623195-706D84FA-33F5-44DA-A3E7-9CCA1C9BF33EQ24629783-C7379842-4A40-436D-91D8-C9DA28780910Q24650068-DDE15555-318D-47FA-8EFD-BFE9C29DAF0AQ26738523-E5A0FA97-1FDD-48A9-8E2B-A01105B84C12Q26750673-B8D4175F-A707-41A4-8464-BBAB04A90955Q26752374-1607CF3A-AC5F-4F4E-BAE3-F03B8EFD0443Q26786578-FA632585-FC30-4C53-AD5F-4C6D0AE989D3Q26798127-7188E8BC-77D1-45DF-923B-AFEB31AA2A66Q26822516-35990F29-E5F0-4CD7-AB79-6B70327149B4Q26827525-7744CABD-46FE-43FE-B276-2B9A6DEAEE06Q26865446-B582D43F-F5C3-4526-8EC3-9B7610A3F4FFQ27004287-1EF63DF8-27CE-4275-95AF-AE6BAE7EE11EQ27010562-076F3113-E048-4A4C-9CCD-60D9B4107592Q27021276-6667EDF3-C5FF-425B-883F-23A8FC4051AEQ27023239-0A9185E1-D1DE-481C-8CB0-B74C2809ECBBQ27025620-E399A60B-896C-4ABD-9C14-EC14413F4CF1Q27025823-C282DE01-174A-4F34-8A07-2545185B219BQ27026324-4FB526A6-4B0B-46A2-8E46-CF1F134E5961Q27322647-B7583C2C-D8FC-43C6-8BE7-B2AA1515C089Q27683721-71D1CAA7-8B09-4C8A-8FAB-22ACF577F530Q27684681-D4549C64-3B02-4F46-B96D-D4EF93BE3D60Q28066204-3C40F10E-5EF9-4FF1-AD5A-4903F81AE547Q28066949-F5AEAE9F-385C-445A-96C0-D64C8B9D29CDQ28068177-6D6A8A38-8E38-4F0D-B776-FEA9DB54B65FQ28069350-B74D76D8-EFFF-42C9-947D-A8E2D987CEB1Q28076496-4C098F40-CF5C-47BC-BED6-4C723CF182C3Q28242526-8B310BCB-3ED7-4B91-85F7-F88879DBF0D0Q28255491-F8FAC377-F183-4FCC-A30F-8FEFD1517BD9Q28274305-11062139-6253-4795-BF00-906E3865BA46Q28506505-E856B3C2-8E74-41CF-BA3F-15651A7FFB9EQ28553220-B0D4A4FD-399F-47E0-B8BA-43AB3F82B744Q28565232-504B11B1-96F1-41A2-8058-D65AE16FC9E3Q28573370-3121E265-C5A3-4B2C-947E-7DEBF8951614Q28652293-500C837C-4414-4A3D-8907-B0E7844BE7EAQ28740839-1F0189B9-37DC-46EC-A7BE-417BA456ADF1Q28748185-EC0BE85A-05DD-4146-A03C-08A2115CEA7D
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Structure and signalling in the IL-17 receptor family
@ast
Structure and signalling in the IL-17 receptor family
@en
Structure and signalling in the IL-17 receptor family
@nl
type
label
Structure and signalling in the IL-17 receptor family
@ast
Structure and signalling in the IL-17 receptor family
@en
Structure and signalling in the IL-17 receptor family
@nl
prefLabel
Structure and signalling in the IL-17 receptor family
@ast
Structure and signalling in the IL-17 receptor family
@en
Structure and signalling in the IL-17 receptor family
@nl
P2860
P3181
P356
P1476
Structure and signalling in the IL-17 receptor family
@en
P2093
Sarah L Gaffen
P2860
P2888
P304
P3181
P356
10.1038/NRI2586
P407
P577
2009-08-01T00:00:00Z
P5875
P6179
1028865109